# Rituximab for Idiopathic Nephrotic Syndrome

> **NCT04494438** · PHASE3 · COMPLETED · sponsor: **Istituto Giannina Gaslini** · enrollment: 30 (actual)

## Conditions studied

- Idiopathic Nephrotic Syndrome

## Interventions

- **DRUG:** Rituximab

## Key facts

- **NCT ID:** NCT04494438
- **Lead sponsor:** Istituto Giannina Gaslini
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04494438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04494438, "Rituximab for Idiopathic Nephrotic Syndrome". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04494438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*